Trial Profile
Correlation between the total B cell count and antibody production in response to Typhim Vi in an immunocompromised population
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Mar 2018
Price :
$35
*
At a glance
- Drugs Typhoid vaccine Vi-polysaccharide (Primary)
- Indications Typhoid
- Focus Therapeutic Use
- 23 Mar 2018 New trial record
- 05 Mar 2018 Results presented at the 2018 Annual Meeting of the American Academy of Allergy, Asthma and Immunology